Table 1.

Baseline characteristics of participants

Characteristics	Intervention group N = 28	Placebo group N = 24	p-Value
Age (years)	28.42 ± 6.10	32.75 ± 15.99	0.222
Height (cm)	163.08 ± 4.51	163.06 ± 4.24	0.983
Marital status (%)
Single  Married  Widow  Divorced	15 (53.6%) 12 (42.9%) 0 (0%) 1 (3.6%)	12 (50.0%) 9 (37.5%) 0 (0%) 3 (12.5)	0.481
History of previous pregnancy (%)
Yes  No	3 (10.7%) 25 (89.3%)	3 (12.5%) 21 (87.5%)	0.841
Duration of PCOS (year)	9.80 ± 6.21	7.48 ± 4.87	0.152
On antidepressant drugs (%)
Yes  No	4 (14.3%) 24 (85.7%)	3 (12.5%) 21 (87.5%)	0.851
On antianxiety drugs (%)
Yes  No	2 (7.1%) 26 (92.9%)	3 (12.5%) 20 (83.3%)	0.431
On menstrual-regulating drugs (%)
Yes  No	5 (55.6%) 23 (53.5%)	4 (44.4%) 20 (46.5%)	1.000
On metformin (%)
Yes  No	3 (42.9%) 25 (55.6%)	4 (57.1%) 20 (44.4%)	0.531

BMI: Body mass index; PCOS: polycystic ovarian syndrome.

Quantitative variables are mean ± SD and qualitative variables are frequency (percentage).